LifeStance Health Group, Inc. (NASDAQ:LFST – Get Rating) was the recipient of a large decline in short interest in the month of January. As of January 15th, there was short interest totalling 8,860,000 shares, a decline of 5.4% from the December 31st total of 9,370,000 shares. Currently, 12.1% of the shares of the company are short sold. Based on an average trading volume of 529,500 shares, the short-interest ratio is presently 16.7 days.
Insider Activity
In other news, insider Warren Gouk sold 15,106 shares of the business's stock in a transaction on Monday, November 7th. The shares were sold at an average price of $7.20, for a total transaction of $108,763.20. Following the completion of the sale, the insider now owns 5,967,991 shares of the company's stock, valued at approximately $42,969,535.20. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 16.59% of the company's stock.
Get
LifeStance Health Group alerts:
Institutional Trading of LifeStance Health Group
A number of large investors have recently made changes to their positions in the business. Dynamic Advisor Solutions LLC bought a new stake in shares of LifeStance Health Group in the 4th quarter worth about $56,000. Bank of New York Mellon Corp increased its holdings in shares of LifeStance Health Group by 29.4% in the 3rd quarter. Bank of New York Mellon Corp now owns 366,857 shares of the company's stock worth $2,429,000 after buying an additional 83,267 shares during the last quarter. Alliancebernstein L.P. increased its holdings in shares of LifeStance Health Group by 24.4% in the 3rd quarter. Alliancebernstein L.P. now owns 95,400 shares of the company's stock worth $632,000 after buying an additional 18,700 shares during the last quarter. State Street Corp grew its holdings in LifeStance Health Group by 22.3% during the 3rd quarter. State Street Corp now owns 1,402,221 shares of the company's stock valued at $9,283,000 after purchasing an additional 256,009 shares during the last quarter. Finally, TCG Advisory Services LLC bought a new position in LifeStance Health Group during the 3rd quarter valued at about $1,936,000. 76.49% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
A number of research firms recently weighed in on LFST. Cowen lowered their target price on shares of LifeStance Health Group from $10.00 to $8.00 and set an "outperform" rating on the stock in a research note on Monday, November 14th. Jefferies Financial Group restated a "buy" rating and set a $7.25 target price on shares of LifeStance Health Group in a research note on Monday, November 7th. Cowen lowered their target price on shares of LifeStance Health Group from $10.00 to $8.00 and set an "outperform" rating on the stock in a research note on Monday, November 14th. Morgan Stanley upgraded shares of LifeStance Health Group from an "equal weight" rating to an "overweight" rating and set a $8.00 target price on the stock in a research note on Friday, January 6th. Finally, The Goldman Sachs Group lowered their target price on shares of LifeStance Health Group from $9.00 to $8.00 and set a "neutral" rating on the stock in a research note on Tuesday, November 15th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $8.21.
LifeStance Health Group Stock Down 4.5 %
Shares of LFST stock opened at $5.29 on Tuesday. The stock has a market cap of $1.99 billion, a P/E ratio of -6.61 and a beta of 0.51. LifeStance Health Group has a 52 week low of $4.22 and a 52 week high of $11.25. The company has a quick ratio of 2.25, a current ratio of 2.25 and a debt-to-equity ratio of 0.14. The company's fifty day simple moving average is $5.06 and its two-hundred day simple moving average is $6.39.
LifeStance Health Group (NASDAQ:LFST – Get Rating) last announced its quarterly earnings results on Tuesday, November 8th. The company reported ($0.11) EPS for the quarter, topping the consensus estimate of ($0.15) by $0.04. The business had revenue of $217.56 million for the quarter, compared to analysts' expectations of $219.69 million. LifeStance Health Group had a negative net margin of 33.77% and a negative return on equity of 18.01%. Analysts predict that LifeStance Health Group will post -0.6 EPS for the current fiscal year.
About LifeStance Health Group
(Get Rating)
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
Featured Stories
- Get a free copy of the StockNews.com research report on LifeStance Health Group (LFST)
- Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
- SoFi Technologies Smashes Earnings but Beware the Fed Decision
- Buying The Dip In Colgate-Palmolive
- Mullen Automotive On Hiring Spree, What Could That Mean?
- InterDigital Raises Its Earnings Guidance
Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
